EcoR1 Capital, LLC's Net Worth

$509 Million

Estimate Recalculated Feb 23, 2024 05:41PM EST

Who is EcoR1 Capital, LLC?

EcoR1 Capital, LLC has an estimated net worth of $509 Million. This is based on reported shares across multiple companies, which include Odonate Therapeutics, Inc., Nuvation Bio Inc., PROTHENA CORP PUBLIC LTD CO, Panacea Acquisition Corp. II, Celladon Corp, Voyager Therapeutics, Inc., ANAPTYSBIO, INC, Surface Oncology, Inc., Corvus Pharmaceuticals, Inc., Zymeworks Inc., Akouos, Inc., Mersana Therapeutics, Inc., TScan Therapeutics, Inc., Graphite Bio, Inc., GENVEC INC, and Tango Therapeutics, Inc..

SEC CIK

EcoR1 Capital, LLC's CIK is 0001587114

Past Insider Trading and Trends

2021 was EcoR1 Capital, LLC's most active year for acquiring shares with 45 total transactions. EcoR1 Capital, LLC's most active month to acquire stocks was the month of January. 2021 was EcoR1 Capital, LLC's most active year for disposing of shares, totalling 9 transactions. EcoR1 Capital, LLC's most active month to dispose stocks was the month of November. 2021 saw EcoR1 Capital, LLC paying a total of $154,143,154.93 for 21,174,343 shares, this is the most they've acquired in one year. In 2022 EcoR1 Capital, LLC cashed out on 1,730,973 shares for a total of $45,294,565.03, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Nuvation Bio Inc. (NUVB) Snapshot price: $1.635

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
+72.17%
5.31M
$1.26
$6,692,265.10
12.67M
Sep 19 - Sep 21
Form 4
+72.17%
5.31M
$1.26
$6,692,265.10
12.67M
Feb 19 - Feb 21
Form 4
+3.07%
488.11K
$8.89
$4,589,360.93
16.41M
Mar 31 - Nov 24
Form 4
+5.89%
464.5K
$9.89
$4,594,593.90
8.35M
Apr 9 - Apr 13
Form 4
+162.95%
12.86M
$10.00
$25,000,000.00
20.75M
Feb 10
Form 4
390K
$10.00
$3,900,000.00
390K
Jul 6
Form 3
0
0
No matching records found

Panacea Acquisition Corp. II No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-545.00K
0
Apr 28
Form 4
545K
$10.00
$5,450,000.00
545K
Apr 9
Form 3
0
0
No matching records found

ANAPTYSBIO, INC (ANAB) Snapshot price: $23.55

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
$21.63
15.04M
May 5
Form 4
+3.03%
221.5K
$23.24
$5,147,443.53
7.52M
Apr 30 - May 4
Form 4
+2.06%
147.3K
$23.63
$3,480,233.08
7.3M
Apr 23 - Apr 27
Form 4
+86.10%
3.31M
$18.93
$62,622,736.04
7.15M
Mar 8 - Mar 9
Form 4
+0.77%
29.5K
$25.48
$751,657.05
3.84M
Feb 23
Form 3
0
0
No matching records found

GENVEC INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1.23%
24.14K
$2.24
$54,082.32
1.99M
May 22 - May 27
Form 4
+6.65%
122.27K
$2.55
$311,982.41
1.96M
Mar 26 - Mar 28
Form 3
0
0
No matching records found

Odonate Therapeutics, Inc. (ODTC) Snapshot price: $3210

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-50.00%
-5.70M
$1.66
-$9,432,401.41
5.7M
Dec 1 - Dec 10
Form 3
0
0
No matching records found